| |
| |
|
| Insider
Information: |
Zeronda Tyler |
| Relationship: |
|
| City: |
Bridgewater |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
131,743 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$29,445 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
131,743 |
|
|
| Total
Value |
$29,445 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
VYNE Therapeutics Inc |
VYNE |
|
2024-04-01 |
131,743 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VYNE |
VYNE Therapeutics Inc |
CHIEF FINANCIAL OFFICER |
• – – |
2024-04-01 |
4 |
D |
$3.08 |
$290 |
D/D |
(94) |
131,743 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Financial Officer |
• – – |
2024-01-02 |
4 |
D |
$2.28 |
$212 |
D/D |
(93) |
131,837 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Financial Officer |
• – – |
2024-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
131,930 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
69,430 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-10-02 |
4 |
D |
$3.83 |
$4,163 |
D/D |
(1,087) |
6,930 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-06-30 |
4 |
D |
$4.10 |
$373 |
D/D |
(91) |
8,017 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-12-31 |
4 |
D |
$0.15 |
$53 |
D/D |
(354) |
173,005 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
CFO |
• – – |
2022-09-30 |
4 |
D |
$0.22 |
$79 |
D/D |
(353) |
173,359 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
CFO |
• – – |
2022-06-30 |
4 |
D |
$0.39 |
$138 |
D/D |
(354) |
173,712 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
CFO |
• – – |
2022-05-31 |
4 |
A |
$0.35 |
$4,332 |
D/D |
12,510 |
174,066 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
CFO |
• – – |
2022-03-31 |
4 |
D |
$0.65 |
$502 |
D/D |
(773) |
161,556 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
CFO |
• – – |
2022-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
162,329 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Interim CFO |
• – – |
2021-12-31 |
4 |
D |
$1.02 |
$210 |
D/D |
(206) |
87,329 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Interim CFO |
• – – |
2021-09-30 |
4 |
D |
$1.39 |
$286 |
D/D |
(206) |
83,348 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Interim CFO |
• – – |
2021-09-02 |
4 |
A |
$0.00 |
$0 |
D/D |
60,859 |
83,554 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Interim CFO |
• – – |
2021-06-30 |
4 |
D |
$3.51 |
$2,457 |
D/D |
(700) |
22,695 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Interim CFOOfficer |
• – – |
2021-06-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
23,395 |
|
% |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
